Key result
Continuous glucose monitoring (CGM) has evolved over 25 years into a key tool for measuring glycemic status and guiding day-to-day diabetes management, transforming diabetes care.
Why the study?
To provide a roadmap outlining past, present, and potential future advances to harness continuous glucose monitoring for diabetes management and ensure broad availability.
This review provides a roadmap for the effective use and implementation of continuous glucose monitoring in diabetes care.
Informs CGM integration into routine diabetes care; leaves open validation of implementation strategies in prospective studies.
For 25 years, continuous glucose monitoring (CGM) has been evolving into what it is now: a key tool to both measure individuals' glycemic status and to help guide their day-to-day management of diabetes. Through a series of engineering innovations, clinical investigations, and efforts to optimize workflow implementation, the use of CGM is helping to transform diabetes care. This article presents a roadmap to the effective use of CGM that outlines past, present, and possible future advances in harnessing the potential of CGM to improve the lives of many people with diabetes, with an emphasis on ensuring that CGM technology is available to all who could benefit from its use.
No takes yet. Share an insight, caveat, or question.
Richard M. Bergenstal (2023) conducted a review in Diabetes. Continuous glucose monitoring (CGM) was evaluated. Continuous glucose monitoring (CGM) has evolved over 25 years into a key tool for measuring glycemic status and guiding day-to-day diabetes management, transforming diabetes care.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: